​

Conduit Pharmaceuticals Ownership | Who Owns Conduit Pharmaceuticals?

OverviewRevenueFinancialsChart

Conduit Pharmaceuticals Ownership Summary

Conduit Pharmaceuticals is owned by 0.21% institutional investors, 13.92% insiders, and 85.86% retail investors. Rhumbline advisers is the largest institutional shareholder, holding 0% of CDT shares.

CDT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockConduit Pharmaceuticals0.21%13.92%85.86%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rhumbline advisers---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rhumbline advisers---

Top Buyers

HolderShares% AssetsChange
Rhumbline advisers---1.03M

Top Sellers

HolderShares% AssetsChange
Rhumbline advisers---1.03M

Sold Out

HolderChange
Rhumbline advisers-1.03M

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20243818.75%8,729,799115.70%-2486.44%3020.00%2-50.00%
Sep 30, 20243210.34%4,047,17538.34%-1480.05%25-433.33%
Jun 30, 20242961.11%2,925,51981.56%-4153.32%2578.57%350.00%
Mar 31, 20241863.64%1,611,34317.18%-2586.37%1427.27%2-
Dec 31, 202311266.67%1,375,05725587.60%-125439150.00%11266.67%--

Recent Insider Transactions

DateNameRoleActivityValue
Oct 03, 2024Nirland Ltd-Sell$156.45K
Oct 07, 2024Nirland Ltd-Sell$96.53K
Oct 04, 2024Nirland Ltd-Sell$140.46K
Oct 01, 2024Nirland Ltd-Sell$141.38K
Sep 30, 2024Nirland Ltd-Sell$122.02K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q4-5
2024 Q3-11
2024 Q211
2023 Q4--

CDT Ownership FAQ

Who Owns Conduit Pharmaceuticals?

Conduit Pharmaceuticals shareholders are primarily institutional investors at 0.21%, followed by 13.92% insiders and 85.87% retail investors. The average institutional ownership in Conduit Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Conduit Pharmaceuticals falls below.

Does Blackrock own Conduit Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Conduit Pharmaceuticals.

Who is Conduit Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Rhumbline advisers is Conduit Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Conduit Pharmaceuticals shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools